KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Taxes: 2022-2023

Historic Current Taxes for Acadia Pharmaceuticals (ACAD) over the last 2 years, with Dec 2023 value amounting to $8.7 million.

  • Acadia Pharmaceuticals' Current Taxes was N/A to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.7 million for FY2023, which is 2210.34% up from last year.
  • Acadia Pharmaceuticals' Current Taxes amounted to $8.7 million in FY2023, which was up 2,210.34% from $377,000 recorded in FY2022.
  • Acadia Pharmaceuticals' Current Taxes' 5-year high stood at $8.7 million during FY2023, with a 5-year trough of $377,000 in FY2022.
  • For the 2-year period, Acadia Pharmaceuticals' Current Taxes averaged around $4.5 million, with its median value being $4.5 million (2022).
  • Data for Acadia Pharmaceuticals' Current Taxes shows a peak YoY spiked of 2,210.34% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Acadia Pharmaceuticals' Current Taxes stood at $377,000 in 2022, then surged by 2,210.34% to $8.7 million in 2023.